Deutsche Bank
http://www.db.com/
Deutsche Bank is a leading global investment bank with a strong and profitable private clients franchise.
The company operates through three divisions: Corporate and Investment Bank (CIB), Private Clients and Asset Management (PCAM) and Corporate Investments (CI) . The CIB division engages in the origination, sale, financing, structuring, and trading of fixed income, equity, equity-linked, convertible bond, foreign exchange, and commodities products. The PCAM segment provides portfolio/fund management products, including active fund management, passive/quantitative fund management, alternative investments, and discretionary portfolio management solutions in Germany and other continental European countries.-
Zoetis (ZTS) Success Could Trigger Animal Healthcare Spin-Off Bonanza
-
Notable Analyst Rating Changes 08/28: (LLY) (MTX) (SDRL) Upgraded; (AKS) (KLAC) (ASML) Downgraded
-
Notable Analyst Rating Changes 07/30: (DNDN) (PSX) (CHS) Upgraded; (JPM) (LLY) (EQIX) Downgraded
-
Notable Analyst Rating Changes 10/28: (AMD) (LLY) (GS) Upgraded; (MDR) (BMY) (ED) Downgraded
-
Wave of Downgrades Hits Amylin, Alkermes, Eli Lilly (AMLN, ALKS, LLY)
-
Notable Analyst Rating Changes 12/16: CNQ, SCHW, RCL, CCL, NLY, GLW, BFS, ADBE Upgraded; AYE, FE, EIX, STLD Downgraded
-
Notable Analyst Rating Changes 10/9: VIA, AKS, SY, MAR, RIMM; ARO, MT, BMY, LTD Downgrade
-
David Moenning’s Daily State of the Markets: 7/22
-
Deutsche Bank Initiates Coverage on Covance (CVD) with a Buy; 'Strategically' Best Suited to Gain Share
-
David Moenning's Daily State of the Markets: 4/20
-
David Moenning's Daily State of the Markets: 10/23
-
Morning Movers 10/06: Citigroup (C) Lower on Wachovia Battle; Imclone (IMCL) Up After Eli Lilly Takeover
-
Analyst Expects Immediate $70/Share Offer for ImClone (IMCL) from Bristol-Myers Following News
-
David Moenning's Daily State of the Markets:
-
David Moenning's Daily State of the Markets: 1/29
-
David Moenning's Daily State of the Markets: 01/07
